|
|
Vol. 10.22 – 9 December, 2024
|
|
|
|
|
|
|
|
Scientists discovered that fructose supplementation enhanced tumour growth in animal models of melanoma, breast cancer, and cervical cancer without causing weight gain or insulin resistance. [Nature]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
DERMAL STEM CELLS & TISSUE REGENERATION
|
|
|
|
|
|
Investigators found that the level of peroxisome proliferator-activated receptor gamma was substantially reduced in the skin lesions of patients, and replicating this reduction in mice led to rapid disease onset with multiple hallmarks of systemic lupus erythematosus.
[Cellular & Molecular Immunology]
|
|
|
|
|
|
Human dermal fibroblasts responded to Etv2, Foxc2, and Fli1 nanoelectroporation with elevated expression of endothelial genes in vitro, which was linked to increased ten-eleven translocase 1/2/3 (TET) expression.
[Nature Communications]
|
|
|
|
|
|
Researchers showed that ultraviolet and α-melanocyte-stimulating hormone triggered cilium formation in human melanocytes and melanoma cells.
[PLOS Biology]
|
|
|
|
|
|
Subsequent silencing of YT521-B homology domain family 2 (YTHDF2) in a psoriatic cell model resulted in a marked decrease in mRNA expression of IL-17A, S100A8, and S100A9, accompanied by a reduction in cell proliferation. Conversely, overexpression of YTHDF2 led to the opposite effects.
[International Immunopharmacology]
|
|
|
|
|
|
Through in vitro experiments with human immortalized keratinocytes (HaCat), researchers found that atorvastatin calcium could significantly reduce the ultraviolet radiation B-induced increased expression of age-related protein p16 and age-related gene p21. [Scientific Reports]
|
|
|
|
|
|
|
|
Scientists used genetically engineered mouse models and patient-derived BRAFV600E-driven melanoma cell lines to dissect the role of PREX2 in melanomagenesis and response to therapy.
[Cancer Research]
|
|
|
|
|
|
To identify tumor-intrinsic modulators of immunity to melanoma, researchers performed a whole-genome CRISPR screen in melanoma and identified Setdb1 as well as all components of the HUSH complex.
[Cancer Immunology Research]
|
|
|
|
|
|
Investigators compared the efficacy and safety of nivolumab to ipilimumab + nivolumab as first-line treatment for metastatic melanoma. A total of 406 patients were treated with nivolumab, and 416 with ipilimumab + nivolumab. [British Journal of Dermatology]
|
|
|
|
|
|
|
|
The authors emphasize the roles and regulatory mechanisms of ferroptosis in melanoma development, the involved immune regulation, as well as the potential for diagnosis and treatment of melanoma. [Biochimica et Biophysica Acta-Reviews on Cancer]
|
|
|
|
|
|
|
|
AiViva Biopharma, Inc. announced the receipt of FDA clearance for testing AIV001 by intradermal injection with their formulation in facial skin. AIV001 is a pan-tyrosine kinase inhibitor in a proprietary formulation, designed for prolonged drug release. [AiViva Biopharma, Inc. (GlobeNewswire)]
|
|
|
|
|
|
|
|
|
January 30-31, 2025 Hamburg, Germany
|
|
|
|
|
|
|
|
|
|
|
Karolinska Institute – Solna, Sweden
|
|
|
|
|
|
|
University of Bradford – Bradford, England, United Kingdom
|
|
|
|
|
|
|
Ulster University – Belfast, Northern Ireland, United Kingdom
|
|
|
|
|
|
|
Spanish National Cancer Research Center – Madrid, Spain
|
|
|
|
|
|
|
Northwell Health – Manhasset, New York, United States
|
|
|
|
|
|